Amedisys Home Health Of Brewton in Brewton, AL - Home Health Agency

Amedisys Home Health Of Brewton is a medicare certified home health care agency in Brewton, Alabama. It is located in Brewton at 2554 Douglas Avenue, Brewton, Alabama 36426. You can reach out to the office of Amedisys Home Health Of Brewton via phone at (251) 809-1717. Amedisys Home Health Of Brewton provide healthcare services in Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide. It has the following ownership type - Proprietary.

Amedisys Home Health Of Brewton is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this home health facility for your medical needs. The medicare CCN number for Amedisys Home Health Of Brewton is 17328 and it was first certified by CMS in 2006 (18 years certified).

Contact Information

Amedisys Home Health Of Brewton
2554 Douglas Avenue, Brewton, Alabama 36426
(251) 809-1717


Home Healthcare Agency Profile

NameAmedisys Home Health Of Brewton
Location2554 Douglas Avenue, Brewton, Alabama
Certified ByMedicare
Services OfferedNursing Care
Physical Therapy
Occupational Therapy
Speech Pathology
Medical Social Services
Home Health Aide
Medicare ID17328
Ownership TypeProprietary
Service Area Zip Codes36401, 36426, 36427, 36432, 36441, 36442, 36483, 36502

NPI for Amedisys Home Health Of Brewton:

Home Healthcare Agencies may have multiple NPI numbers. We have found possible NPI number/s associated with Amedisys Home Health Of Brewton from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1356309520
Organization NameAMEDISYS HOME HEALTH OF ALABAMA, LLC
Doing Business AsAMEDISYS HOME HEALTH OF BREWTON
Address2554 Douglas Ave, Brewton, AL 36426
Phone Number251-809-1717

News Archive

Proteins Nox1 and Nox2 play important role in amyotrophic lateral sclerosis

University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

Boehringer Ingelheim to commence volasertib plus LDAC Phase III study for AML

New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.

PPD reports net revenue of $383.2 million for first quarter 2011

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2011.

Read more Medical News

› Verified 2 days ago

Quality Ratings:

Amedisys Home Health Of Brewton is "Medicare-certified" which means that this home health agency is approved by Medicare and meets certain federal health and safety requirements, however, home health agencies may vary in the quality of care and services they provide to their patients. The quality ratings gives you an indication of the care Amedisys Home Health Of Brewton give to their patients incomparison to other home health agencies. This quality rating is based on process quality measures and patient outcome measures survey conducted by CMS.

Quality Rating:

News Archive

Proteins Nox1 and Nox2 play important role in amyotrophic lateral sclerosis

University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

Boehringer Ingelheim to commence volasertib plus LDAC Phase III study for AML

New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.

PPD reports net revenue of $383.2 million for first quarter 2011

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2011.

Read more Medical News

› Verified 2 days ago

Process Quality Measures:

The below quality measures show how often Amedisys Home Health Of Brewton used best practices when caring for its patients (process measures). Amedisys Home Health Of Brewton quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often the home health team began their patients’ care in a timely manner10095.7
How often the home health team taught patients (or their family caregivers) about their drugs10098.6
How often the home health team checked patients’ risk of falling10099.6
How often the home health team checked patients for depression95.197.4
How often the home health team made sure that their patients have received a flu shot for the current flu season.91.878.7
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot).91.582.2
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care99.696.4

News Archive

Proteins Nox1 and Nox2 play important role in amyotrophic lateral sclerosis

University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

Boehringer Ingelheim to commence volasertib plus LDAC Phase III study for AML

New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.

PPD reports net revenue of $383.2 million for first quarter 2011

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2011.

Read more Medical News

› Verified 2 days ago

Patient Outcome Quality Measures:

The below quality measures show whether patients with Amedisys Home Health Of Brewton improved in certain important areas of care (patient outcome). Amedisys Home Health Of Brewton quality data is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Quality MeasureProviderNational Avg.
How often patients got better at walking or moving around9079.6
How often patients got better at getting in and out of bed89.481.1
How often patients got better at bathing96.782.3
How often patients’ breathing improved93.482.8
How often patients’ wounds improved or healed after an operation-92.3
How often patients got better at taking their drugs correctly by mouth8775
How often home health patients had to be admitted to the hospital20.715.4
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted16.113
How often physician-recommended actions to address medication issues were completely timely99.694

News Archive

Proteins Nox1 and Nox2 play important role in amyotrophic lateral sclerosis

University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

Boehringer Ingelheim to commence volasertib plus LDAC Phase III study for AML

New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.

PPD reports net revenue of $383.2 million for first quarter 2011

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2011.

Read more Medical News

› Verified 2 days ago

Patients' Survey and Ratings:

The patient experience of care survey collects patient (or their family or friend's) feedback about topics for which the patient is the best source of information. When choosing a home health agency, patients can use this information to find out what other patients thought about the care given by a certain home health agency. The total number of patients who responded in this survey for Amedisys Home Health Of Brewton are 159.
Question Type:Rating by Patients
Health team gave care in a professional way
Health team communicated well with them
Health team discussed medicines, pain, and home safety
How patients rated overall care from agency

News Archive

Proteins Nox1 and Nox2 play important role in amyotrophic lateral sclerosis

University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

Boehringer Ingelheim to commence volasertib plus LDAC Phase III study for AML

New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.

PPD reports net revenue of $383.2 million for first quarter 2011

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2011.

Read more Medical News

› Verified 2 days ago

The patient survey data of Amedisys Home Health Of Brewton is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percent of patients who reported that their home health team gave care in a professional way9388
Percent of patients who reported that their home health team communicated well with them9385
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them9283
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest)9284
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family9078

News Archive

Proteins Nox1 and Nox2 play important role in amyotrophic lateral sclerosis

University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Cook Medical launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for treating PAD

In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

Boehringer Ingelheim to commence volasertib plus LDAC Phase III study for AML

New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.

PPD reports net revenue of $383.2 million for first quarter 2011

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2011.

Read more News

› Verified 2 days ago

Home Healthcare Agencies in Brewton, AL

D W Mcmillan Home Health
Location: 114 W Jackson Street, Brewton, Alabama 36426
Ratings:

Phone: (251) 867-5054    
Amedisys Home Health Of Brewton
Location: 2554 Douglas Avenue, Brewton, Alabama 36426
Ratings:

Phone: (251) 809-1717    

Home Health Care

Home health care is a wide range of health care services that can be given in your home for an illness or injury. Home health care is usually less expensive, more convenient, and just as effective as care you get in a hospital or skilled nursing facility (SNF). The goal of home health care is to treat an illness or injury. Home health care helps you get better, regain your independence, and become as self-sufficient as possible.

Home Healthcare Agency Compare

Home Health Compare has information about the quality of care provided by "Medicare-certified" home health agencies throughout the nation. "Medicare-certified" means the home health agency is approved by Medicare and meets certain federal health and safety requirements. Home Health Compare can help you or your family or friends choose a quality home health agency that has the skilled home health services you need.

Home Health Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (DHHS).

NOTE: Medicare won't cover home health services provided by a home health agency that hasn't been Medicare-certified.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.